---
title: "Charles Saunders, MD: Biosimilars in Specialty Pharmacy"
description: Charles Saunders, MD, CEO of Integra Connect, discusses the promise of biosimilars in specialty pharmacy.
---

# Newsroom

For Press Contact

[media@integraconnect.com](mailto:media@integraconnect.com)

Announcements

[In The News](https://insights.integraconnect.com/news?type=in-the-news) [Thought Leadership](https://insights.integraconnect.com/news?type=thought-leadership)

[

Back

](https://insights.integraconnect.com/news?type=in-the-news)

### Charles Saunders, MD: Biosimilars in Specialty Pharmacy

Dec 18, 2018

Life Sciences

Specialty Practices

Click here to [read the original article at AJMC.](https://www.centerforbiosimilars.com/view/charles-saunders-md-biosimilars-in-specialty-pharmacy)

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Integra Connect",
    "url" : "https://insights.integraconnect.com/news/author/integra-connect"
  },
  "dateModified" : "2023-05-24T02:15:50.714Z",
  "datePublished" : "2018-12-18T14:00:00.000Z",
  "headline" : "Charles Saunders, MD: Biosimilars in Specialty Pharmacy",
  "mainEntityOfPage" : {
    "@id" : "https://insights.integraconnect.com/news/biosimilars-in-specialty-pharmacy",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://insights.integraconnect.com/hubfs/IntegraConnect%20/ic-logo-text-dark-gray.png"
    },
    "name" : "Integra Connect"
  }
}
```